The association between antineutrophil cytoplasmic antibody-associated vasculitis (AAV) and cancer remains poorly understood. In this study, we searched the Korea National Health Insurance Claims Database to obtain data for 2097 AAV patients, and evaluated the risk of cancers in AAV. The standardized incidence ratios (SIRs) of overall and site-specific cancers were estimated in patients with AAV compared to the general population. The overall risk of cancer was significantly higher in patients with AAV (SIR 1.90); this remained true in both males (SIR 1.74) and females (SIR 2.06). For site-specific cancers, the risks of lung (SIR 2.23) and hematological (SIR 11.39) cancers were higher in AAV patients. For males, the risks of gallbladder and...
OnlinePubl.Objective: The study objective was to compare incident cancer rates among patients with a...
Objective. In the light of previous reports of an association between malignancy and renal vasculiti...
<p><sup>a</sup> Standardized incidence rate and 95% confidence interval</p><p><sup>b</sup> Percentag...
OBJECTIVES: We investigated the incidence rate and type of cancer, and furthermore, estimated the st...
Objectives Because standard immunosuppressive treatment for antineutrophil cytoplasm antibody-associ...
OBJECTIVES: /st> Because standard immunosuppressive treatment for antineutrophil cytoplasm antibody-...
Objectives Because standard immunosuppressive treatment for antineutrophil cytoplasm antibody-associ...
Objective. Patients with ANCA-associated vasculitides (AAV) exhibit higher rates of malignancy than ...
In this review, we summarise the current understanding of the potential link between cancer and anti...
Antineutrophil cytoplasmic antibody-associated vasculitis (AAV) is a group of systemic necrotising v...
The purpose of this paper is to examine cancer incidence in patients with ANCA-associated vasculitis...
<div><p>Objective</p><p>The purpose of this paper is to examine cancer incidence in patients with AN...
Background. Immunosuppressive therapy for antineutrophil cytoplasmic antibody-associated vasculitis ...
Objectives: The incidence and prevalence of AAV in Asia remain poorly understood, especially in a na...
Background: We investigated and compared the initial clinical features at diagnosis and the poor out...
OnlinePubl.Objective: The study objective was to compare incident cancer rates among patients with a...
Objective. In the light of previous reports of an association between malignancy and renal vasculiti...
<p><sup>a</sup> Standardized incidence rate and 95% confidence interval</p><p><sup>b</sup> Percentag...
OBJECTIVES: We investigated the incidence rate and type of cancer, and furthermore, estimated the st...
Objectives Because standard immunosuppressive treatment for antineutrophil cytoplasm antibody-associ...
OBJECTIVES: /st> Because standard immunosuppressive treatment for antineutrophil cytoplasm antibody-...
Objectives Because standard immunosuppressive treatment for antineutrophil cytoplasm antibody-associ...
Objective. Patients with ANCA-associated vasculitides (AAV) exhibit higher rates of malignancy than ...
In this review, we summarise the current understanding of the potential link between cancer and anti...
Antineutrophil cytoplasmic antibody-associated vasculitis (AAV) is a group of systemic necrotising v...
The purpose of this paper is to examine cancer incidence in patients with ANCA-associated vasculitis...
<div><p>Objective</p><p>The purpose of this paper is to examine cancer incidence in patients with AN...
Background. Immunosuppressive therapy for antineutrophil cytoplasmic antibody-associated vasculitis ...
Objectives: The incidence and prevalence of AAV in Asia remain poorly understood, especially in a na...
Background: We investigated and compared the initial clinical features at diagnosis and the poor out...
OnlinePubl.Objective: The study objective was to compare incident cancer rates among patients with a...
Objective. In the light of previous reports of an association between malignancy and renal vasculiti...
<p><sup>a</sup> Standardized incidence rate and 95% confidence interval</p><p><sup>b</sup> Percentag...